亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢康寶泰精細化工有限公司武昌一分部  

精細化學品,化工中間體,原料藥

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:付經理
  • 電話:027-87738651
  • QQ:664219562
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 23327-57-3 ***奈福泮
23327-57-3 ***奈福泮
單價 1.00 / 千克對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 1000千克起訂1千克
品牌 康寶泰
型號 23327-57-3
規格 25
過期 長期有效
更新 2013-11-25 13:29
 
詳細信息


聯 系 人:陳永鵬
聯系電話:027-87738651 歸屬地:湖北 武漢
電子郵件:2593677460@qq.*
聯系地址:武漢市武昌區武珞路
***奈福泮  CP2010
中文名稱: ***奈福泮
中文同義詞: ***萘福泮;5-甲基-1-苯基-3,4,5,6-四氫-1H-2,5-氧氮苯并辛因***;***奈福泮;******氧辛啶;①奈福泮②平痛新;***平痛新 別名;***平痛新(奈福泮)
英文名稱: Nefopam hydrochloride
英文同義詞: 5-benzoxazocine,5-methyl-1-phenyl-3,4,5,6-tetrahydro-1h-hydrochloride;5-methyl-1-phenyl-3,4,5,6-tetrahydro-1h-2,5-benzoxazocinehydrochloride;ajan;fenazoxinehydrochloride;r738;BENZOXAZOCINE HYDROCHLORIDE;LABOTEST-BB LT00159839;ACUPAN
CAS號: 23327-57-3
分子式: C17H20ClNO
分子量: 289.8
EINECS號: 245-585-5
白色結晶性粉末
該品系非成癮性鎮痛藥,兼有肌松作用。適用于各種手術后疼、癌癥疼痛、內臟平滑肌絞痛等

 陳先生:027-87738651    QQ:2656853628
 

©2025 武漢康寶泰精細化工有限公司武昌一分部 版權所有   技術支持:化工網   訪問量:26909  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |